A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

NCT03328364 · clinicaltrials.gov ↗

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer

Interventions

DRUG: enzalutamide
DRUG: docetaxel

Sponsor

Astellas Pharma a/s